These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1252 related articles for article (PubMed ID: 31888566)

  • 1. Androgen receptor and FOXA1 coexpression define a "luminal-AR" subtype of feline mammary carcinomas, spontaneous models of breast cancer.
    Dagher E; Royer V; Buchet P; Abadie J; Loussouarn D; Campone M; Nguyen F
    BMC Cancer; 2019 Dec; 19(1):1267. PubMed ID: 31888566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of an immune-suppressed subtype of feline triple-negative basal-like invasive mammary carcinomas, spontaneous models of breast cancer.
    Dagher E; Simbault L; Abadie J; Loussouarn D; Campone M; Nguyen F
    Tumour Biol; 2020 Jan; 42(1):1010428319901052. PubMed ID: 31959092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bcl-2 expression and prognostic significance in feline invasive mammary carcinomas: a retrospective observational study.
    Dagher E; Abadie J; Loussouarn D; Fanuel D; Campone M; Nguyen F
    BMC Vet Res; 2019 Jan; 15(1):25. PubMed ID: 30630524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unfavorable Prognostic Effects of the Stem Cell Pluripotency Factor Sox2 in Feline Invasive Mammary Carcinomas.
    Truchot Y; Dagher E; Abadie J; Nguyen F
    Front Vet Sci; 2020; 7():622019. PubMed ID: 33553286
    [No Abstract]   [Full Text] [Related]  

  • 5. Triple-negative vimentin-positive heterogeneous feline mammary carcinomas as a potential comparative model for breast cancer.
    Caliari D; Zappulli V; Rasotto R; Cardazzo B; Frassineti F; Goldschmidt MH; Castagnaro M
    BMC Vet Res; 2014 Sep; 10():185. PubMed ID: 25249140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coexpression of androgen receptor and FOXA1 in nonmetastatic triple-negative breast cancer: ancillary study from PACS08 trial.
    Guiu S; Charon-Barra C; Vernerey D; Fumoleau P; Campone M; Spielmann M; Roché H; Mesleard C; Arnould L; Lemonnier J; Lacroix-Triki M
    Future Oncol; 2015; 11(16):2283-97. PubMed ID: 26260807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of androgen receptor and FOXA1 co-expression in non-metastatic triple negative breast cancer and correlation with other biomarkers.
    Guiu S; Mollevi C; Charon-Barra C; Boissière F; Crapez E; Chartron E; Lamy PJ; Gutowski M; Bourgier C; Romieu G; Simony-Lafontaine J; Jacot W
    Br J Cancer; 2018 Jul; 119(1):76-79. PubMed ID: 29880907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FOXA1 expression in breast cancer--correlation with luminal subtype A and survival.
    Badve S; Turbin D; Thorat MA; Morimiya A; Nielsen TO; Perou CM; Dunn S; Huntsman DG; Nakshatri H
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4415-21. PubMed ID: 17671124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Canine invasive mammary carcinomas as models of human breast cancer. Part 2: immunophenotypes and prognostic significance.
    Abadie J; Nguyen F; Loussouarn D; Peña L; Gama A; Rieder N; Belousov A; Bemelmans I; Jaillardon L; Ibisch C; Campone M
    Breast Cancer Res Treat; 2018 Jan; 167(2):459-468. PubMed ID: 29063312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FOXA1 represses the molecular phenotype of basal breast cancer cells.
    Bernardo GM; Bebek G; Ginther CL; Sizemore ST; Lozada KL; Miedler JD; Anderson LA; Godwin AK; Abdul-Karim FW; Slamon DJ; Keri RA
    Oncogene; 2013 Jan; 32(5):554-63. PubMed ID: 22391567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Forkhead box A1 expression in breast cancer is associated with luminal subtype and good prognosis.
    Thorat MA; Marchio C; Morimiya A; Savage K; Nakshatri H; Reis-Filho JS; Badve S
    J Clin Pathol; 2008 Mar; 61(3):327-32. PubMed ID: 18037662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. St Gallen molecular subtypes in feline mammary carcinoma and paired metastases-disease progression and clinical implications from a 3-year follow-up study.
    Soares M; Correia J; Peleteiro MC; Ferreira F
    Tumour Biol; 2016 Mar; 37(3):4053-64. PubMed ID: 26486327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feline mammary basal-like adenocarcinomas: a potential model for human triple-negative breast cancer (TNBC) with basal-like subtype.
    Wiese DA; Thaiwong T; Yuzbasiyan-Gurkan V; Kiupel M
    BMC Cancer; 2013 Sep; 13():403. PubMed ID: 24004841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnostic and prognostic significance of FOXA1 expression in molecular subtypes of breast invasive ductal carcinomas].
    Liu N; Niu Y; Wang SL; Yu Q; Zhang RJ; Liu TJ
    Zhonghua Yi Xue Za Zhi; 2010 May; 90(20):1403-7. PubMed ID: 20646630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative gene expression study highlights molecular similarities between triple negative breast cancer tumours and feline mammary carcinomas.
    Sommerville L; Howard J; Evans S; Kelly P; McCann A
    Vet Comp Oncol; 2022 Jun; 20(2):535-538. PubMed ID: 35006637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The dog as a naturally-occurring model for insulin-like growth factor type 1 receptor-overexpressing breast cancer: an observational cohort study.
    Jaillardon L; Abadie J; Godard T; Campone M; Loussouarn D; Siliart B; Nguyen F
    BMC Cancer; 2015 Oct; 15():664. PubMed ID: 26449867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of mammalian target of rapamycin (mTOR) in triple negative feline mammary carcinomas.
    Maniscalco L; Millán Y; Iussich S; Denina M; Sánchez-Céspedes R; Gattino F; Biolatti B; Sasaki N; Nakagawa T; Di Renzo MF; de Las Mulas JM; De Maria R
    BMC Vet Res; 2013 Apr; 9():80. PubMed ID: 23587222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of androgen receptor and forkhead-box A1 protein in apocrine breast carcinoma.
    Sasahara M; Matsui A; Ichimura Y; Hirakata Y; Murata Y; Marui E
    Anticancer Res; 2014 Mar; 34(3):1261-7. PubMed ID: 24596370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apocrine carcinoma as triple-negative breast cancer: novel definition of apocrine-type carcinoma as estrogen/progesterone receptor-negative and androgen receptor-positive invasive ductal carcinoma.
    Tsutsumi Y
    Jpn J Clin Oncol; 2012 May; 42(5):375-86. PubMed ID: 22450930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FOXA1 is an independent prognostic marker for ER-positive breast cancer.
    Mehta RJ; Jain RK; Leung S; Choo J; Nielsen T; Huntsman D; Nakshatri H; Badve S
    Breast Cancer Res Treat; 2012 Feb; 131(3):881-90. PubMed ID: 21503684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 63.